Superiority of Artificial Intelligence in the Diagnostic Performance of Malignant Melanoma Compared to Dermatologists and Primary Care Providers
preprintposted on 04.05.2022, 21:09 authored by Jane AndersonJane Anderson, Izhaar Tejani, Tory Jarmain, Lisa Kellett, Ronald Moy
This IRB approved study assessed the performance of Triage, an AI application, in determining the malignancy of lesions. The images were ran through the Triage application and the same images were assessed by primary care physicians and dermatologists. The top diagnosis given by the AI application was taken into account while the medical providers were asked to label the images as benign or malignant.